Skip to content
Biodatica
Start free

Investigator

Jorge J Palop

J. DAVID GLADSTONE INSTITUTES · funded by NIA

Companies
4

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$4.0M

Summed across those awards.

First award
Aug 15, 2021

Latest Aug 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R61

    Enhancer-AAVs to monitor and restore cell-type selective inhibitory deficits and circuit dysfunction in humanized Alzheimer's disease models

    $1.5M

    Aug 1, 2025NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11210318 (opens the source filing in a new tab)

  2. R01

    Harnessing novel machine learning approaches for behavioral segmentation and brain signal integration in humanized models of Alzheimer's disease

    $817k

    Jun 15, 2025NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11116747 (opens the source filing in a new tab)

  3. R01

    Harnessing novel machine learning approaches for behavioral segmentation and brain signal integration in humanized models of Alzheimer's disease

    $817k

    Jun 15, 2025NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11350907 (opens the source filing in a new tab)

  4. P01

    Project 2: Co-pathogenic Interactions between ApoE Isoforms and Abeta in Neural Network Dysfunction of Alzheimer's Disease

    $897k

    Aug 15, 2021NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11166572 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources